Muye Xia

机构：Cystic Fibrosis Trust, Nanfang Hospital, Guangdong Provincial Center for Disease Control and Prevention, Southern Medical University

发表论文 24 篇 · 总被引 279 次 · h-index 10

代表论文

• Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs (2018 · Infection and Drug Resistance · 被引 43)
• A noninvasive diagnostic model to assess nonalcoholic hepatic steatosis in patients with chronic hepatitis B (2016 · Therapeutic Advances in Gastroenterology · 被引 41)
• Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudine (2017 · Medicine · 被引 34)
• Serum hepatitis B virus RNA level is associated with biochemical relapse in patients with chronic hepatitis B infection who discontinue nucleos(t)ide analogue treatment (2021 · Alimentary Pharmacology & Therapeutics · 被引 25)
• Serum Hepatitis B Virus RNA Levels Predict HBeAg Seroconversion and Virological Response in Chronic Hepatitis B Patients with High Viral Load Treated with Nucleos(t)ide Analog (2020 · Infection and Drug Resistance · 被引 24)
• Circulating miR-122 Is a Predictor for Virological Response in CHB Patients With High Viral Load Treated With Nucleos(t)ide Analogs (2019 · Frontiers in Genetics · 被引 15)